Business Context and Reporting Period
This Form 6-K filing by MDxHealth SA covers the month of November 2021. The filing primarily documents the completion of the Company's initial public offering (IPO) in the United States and the subsequent amendment of its Articles of Association to reflect a capital increase.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial data disclosed relates to the capital structure changes resulting from the IPO:
- Share Capital Increase: Increased from EUR 90,132,067.69 to EUR 118,662,067.69.
- Shares Issued: 37,500,000 new ordinary shares were issued.
- Outstanding Shares: Total ordinary shares increased from 118,469,226 to 155,969,226.
- Offering Details: The Company sold 3,750,000 American Depositary Shares (ADS), with each ADS representing 10 ordinary shares.
Material Changes
The material change reported is the successful completion of the IPO and the corresponding expansion of the Company's share capital and outstanding share count. The Articles of Association were amended on November 8, 2021, to account for these changes.
Guidance, Outlook, and Risks
The filing text does not contain management commentary on future guidance, outlook, specific risks, or contingencies beyond the procedural announcement of the capital increase. The press release attached as Exhibit 99.1 is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the final offering price per ADS and total gross proceeds raised in the IPO (not explicitly stated in this text).
- Confirm the use of proceeds from the capital increase as detailed in the attached press release (Exhibit 99.1).
- Review the amended Articles of Association (Exhibit 3.1) for any new governance provisions.
- Check for any underwriting options or lock-up agreements associated with the 3,750,000 ADS sold.